Bon GSKD
Di bawah adalah senarai bon-bon korporat GSK PLC CEDEAR EACH REPR 1/4 ADR (USD). Pelabur selalunya memilih bon syarikat kerana kestabilan meningkat mereka semasa ketidakstabilan pasaran. Kaji harga, hasil dan statistik lain dan cari pelaburan yang boleh dipercayai.
Simbol | YTM % | Volum | Harga % | Kupon % | Tarikh Matang | Jumlah tertunggak | Nilai muka | Jumlah denominasi min | Pengeluar |
|---|---|---|---|---|---|---|---|---|---|
| XXS217060907GLAXOSM.CAP. MTN 20/35MTN | 6.08% | 0 | 72.65% | 1.63% | 2035-05-12 | 750 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| 117RIGLAXOSMITHKLINE CAPITAL PLC 4.25% GTD SNR EMTN 18/12/45 | 6.06% | 8.46 K | 82.51% | 4.25% | 2045-12-18 | 370.79 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| GGSK3981911GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043 | 5.96% | 60 K | 84.83% | 4.20% | 2043-03-18 | 500 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| 883GIGLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 10/04/2042 | 5.90% | 0 | 94.55% | 5.25% | 2042-04-10 | 477.82 M GBP | 1,000.00 GBP | 50,000.00 GBP | GlaxoSmithKline Capital Plc |
| 771ZCGLAXOSMITHKLINE CAPITAL PLC 6.375% GTD SNR EMTN 09/03/39 | 5.40% | 0 | 107.63% | 6.38% | 2039-03-09 | 631.3 M GBP | 1,000.00 GBP | 50,000.00 GBP | GlaxoSmithKline Capital Plc |
| GGSK6023693GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035 | 5.03% | 8.05 M | 99.01% | 4.88% | 2035-04-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| GGSK.GJGlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038 | 5.02% | 3.73 M | 110.58% | 6.38% | 2038-05-15 | 2.75 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| AAG99GLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 19/12/2033 | 4.67% | 0 | 103.48% | 5.25% | 2033-12-19 | 574.17 M GBP | 1,000.00 GBP | 1,000.00 GBP | GlaxoSmithKline Capital Plc |
| 772WIGLAXOSMITHKLINE CAPITAL INC 5.375% GTD SNR NTS 15/04/2034 | 4.57% | 0 | 105.28% | 5.38% | 2034-04-15 | 500 M USD | 1,000.00 USD | 1,000.00 USD | GlaxoSmithKline Capital, Inc. |
| GGSK6023692GlaxoSmithKline Capital Plc FRN 12-MAR-2027 | 4.53% | 250 K | 100.47% | 4.84% | 2027-03-12 | 600 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital Plc |
| GGSK6023695GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030 | 4.40% | 2.69 M | 100.38% | 4.50% | 2030-04-15 | 850 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| UUS377373AH8GLAXOSM.CAP. 19/29 | 4.40% | 0 | 96.62% | 3.38% | 2029-06-01 | 1 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital Plc |
| UUS377372AN7GLAXOSMITHKLINE CAP.18/28 | 4.29% | 0 | 98.95% | 3.88% | 2028-05-15 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| XXS217060184GLAXOSM.CAP. MTN 20/28MTN | 4.25% | 0 | 91.51% | 1.25% | 2028-10-12 | 750 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| GGSK6023691GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027 | 4.06% | 540 K | 100.39% | 4.32% | 2027-03-12 | 400 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital Plc |
| XXS293369275GSK CAP B.V. 24/36 MTN | 3.59% | 0 | 97.23% | 3.25% | 2036-11-19 | 600 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| XXS255381776GSK CAP B.V. 22/32 MTN | 3.25% | 0 | 99.25% | 3.13% | 2032-11-28 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| XXS293369143GSK CAP B.V. 24/31 MTN | 3.08% | 0 | 98.92% | 2.88% | 2031-11-19 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| XXS182282979GLAXOSM.CAP. MTN 18/30MTN | 2.90% | 0 | 95.12% | 1.75% | 2030-05-21 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| XXS168152035GLAXOSM.CAP. MTN 17/29 | 2.65% | 0 | 95.24% | 1.38% | 2029-09-12 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| XXS255381768GSK CAP B.V. 22/27 MTN | 2.38% | 0 | 101.37% | 3.00% | 2027-11-28 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| GGX5BGLAXOSM.CAP. MTN 17/26 | 2.22% | 0 | 98.65% | 1.00% | 2026-09-12 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| XXS182282812GLAXOSM.CAP. MTN 18/26MTN | 2.07% | 0 | 99.34% | 1.25% | 2026-05-21 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| 117RNGLAXOSMITHKLINE CAPITAL PLC 3.375% GTD SNR EMTN 20/12/2027 | 0.84% | 0 | 112.19% | 3.38% | 2027-12-20 | 307.77 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| AAQ72GLAXOSMITHKLINE CAPITAL PLC 0.883% GTD SNR EMTN 21/09/20 | — | — | — | 0.88% | 2028-09-21 | 42.5 B JPY | 100,000,000.00 JPY | 100,000,000.00 JPY | GlaxoSmithKline Capital Plc |